Advanced Medical Solutions

Advanced Medical Solutions has extended the “put up or shut up” deadline for H.B. Fuller to 2 July 2026 at 17:00 London time. The Takeover Panel approved the extension; the original deadline expired today. The parties continue to hold talks, no firm offer has been confirmed, and the AMS board is advising shareholders to take no action for now. » Więcej na de.investing.com

Advanced Medical Solutions has sent its annual report and financial statements for the year ended 31 December 2025, together with the invitation to the annual general meeting, to shareholders. The AGM will be held on 17 June 2026 at 11:00 in the offices of Investec Bank, 30 Gresham Street, London. The annual report, financial statements and proxy form are available in the investor relations section of the company's website. » Więcej na de.investing.com

Advanced Medical Solutions reported 2025 revenue of £228.9m and adjusted EBITDA of £49.9m (adjusted EBITDA margin 21.8%), in line with the January update and analyst consensus. The Surgical division grew 36% at constant currency and was a major contributor; Woundcare rose 9% at constant currency. Margins were 24.4% (Surgical) and 13.6% (Woundcare); EPS came in 3% below the FactSet consensus due to higher interest expenses. Synergies from the acquisitions of Peters and Syntacoll are progressing as planned, and the company expects 2026 revenue and EBITDA to be in line with market expectations, with strong cash generation to reduce debt. » Więcej na de.investing.com